Literature DB >> 11317618

Dramatic parasomnias.

G Stores1.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11317618      PMCID： PMC1281387          DOI： 10.1177/014107680109400405

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  5 in total

Review 1.  Confusions concerning sleep disorders and the epilepsies in children and adolescents.

Authors:  G Stores
Journal:  Br J Psychiatry       Date:  1991-01       Impact factor: 9.319

2.  Medical student education in sleep and its disorders.

Authors:  G Stores; C Crawford
Journal:  J R Coll Physicians Lond       Date:  1998 Mar-Apr

3.  It's time to wake up to the importance of sleep disorders.

Authors:  W C Dement; M M Mitler
Journal:  JAMA       Date:  1993 Mar 24-31       Impact factor: 56.272

Review 4.  Medical-legal aspects of sleep medicine.

Authors:  M W Mahowald; C H Schenck
Journal:  Neurol Clin       Date:  1999-05       Impact factor: 3.806

5.  Frontal lobe complex partial seizures in children: a form of epilepsy at particular risk of misdiagnosis.

Authors:  G Stores; Z Zaiwalla; N Bergel
Journal:  Dev Med Child Neurol       Date:  1991-11       Impact factor: 5.449
  5 in total
  3 in total

1.  Idiopathic laryngeal spasm: management and long-term outcome.

Authors:  Darren Pinder; Stephen E McDonald; Mark Medcalf; Michael W Bridger
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-10-11       Impact factor: 2.503

2.  Adult-onset NREM parasomnia with hypnopompic hallucinatory pain: a case report.

Authors:  Laura Mantoan; Sofia H Eriksson; Angus P Nisbet; Matthew C Walker
Journal:  Sleep       Date:  2013-02-01       Impact factor: 5.849

3.  Subjective sleep score is associated with central and peripheral blood pressure values in children aged 7-12 years.

Authors:  Felicia R Berube; Elissa K Hoopes; Michele N D'Agata; Freda Patterson; Stephen J Ives; William B Farquhar; Melissa A Witman
Journal:  J Sleep Res       Date:  2021-07-20       Impact factor: 3.981
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.